Breast cancer; tumor neovasculature and the effect of tissue inhibitor of metalloproteinases-1 (TIMP-1) on angiogenesis

In Vivo

Volumn 10, Issue 2, 1996, Pages 137-144

  Thorgeirsson, Unnur P ^a   Yoshiji, Hitoshi ^a   Sinha, Constance C ^a   Gomez, Daniel E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Angiogenesis; Breast cancer; TIMP 1

Indexed keywords

METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; NEOVASCULARIZATION (PATHOLOGY); TUMOR VASCULARIZATION;

EID: 0030030465     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Weidner N, Semple J, Welch, W and Folkman J: Tumor angiogenesis correlates with metastasis in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
2. Bosari S, Lee AKC, DeLellis RA, Wiley BD, Heatley GJ and Silverman ML: Microvessel quantitation and prognosis in invasive breast carcinoma. Human Pathol 23: 755-761, 1992.
3. Folkman J and Shing Y: Angiogenesis. J Biol Chem 267: 10931-10934, 1992.
4. Baillie CT, Winslet MC and Bradley NJ: Tumor vasculature - a potential therapeutic target. Br J Cancer 72: 257-267, 1995.
5. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1: 27-31, 1995.
6. Battegay EJ: Angiogenesis: mechanistic insights, neovascular diseases and therapeutic prospects. J Mol Med 73: 333-346, 1995.
7. Johnson MD, Kim HRC, Chesler L, Tsao-Wu G, Bouck N and Polverini PJ: Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol 160: 194-202, 1994.
8. Montesano R: Maek Forster Award Lecture. Review. Regulation of angiogenesis in vitro. Eur J Clin Invest 22: 504-515, 1992.
9. Gasson JC, Golde DW, Kaufman SE, Westbrook CA, Hewick RM, Kaufman RF, Wong GG, Temple PA, Leary AC, Brown EL, Orr EC and Clark SC: Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature 315: 768-771, 1985.
10. Thorgeirsson UP, Liotta LA, Kalebic T, Margulies IM, Thomas K, Rios-Candelore M and Russo RG: Effect of natural protease inhibitors and a chemoattractant on tumor cell invasion in vitro. J Natl Cancer Inst 69: 1049-1054, 1982.
11. DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE and Taylor SM. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 52: 701-708, 1992.
12. Hayakawa T, Yamoshita K, Tanzawa K, Uchijima E and Iwata K: Growth-promoting activity of tissue inhibitor of metalloproteinase-1 (TIMP-1) for a wide range of cells. FEBS Lett 298: 29-32, 1992.
13. Boujrad N, Ogwuegbu SO, Garnier M, Lee C-H, Martin BM and Papadopoulos V: Identification of a stimulator of steroid hormone synthesis isolated from testis. Science 265: 1609-1612, 1995.
14. Agrez MV, Meldrum CI, Sim ATR, Aebersold RH, Clark IM, Cawston TE and Burns GF: A fibroblast elongation factor purified from colon carcinoma cells shares sequence identity with TIMP-1. Biochem Biophys Res Commun 206: 590-600, 1995.
15. Hsu SM, Raine L and Fanger H: Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580, 1981.
16. Gomez DE, Lindsay CK, Cottam DW, Nason AM and Thorgeirsson UP: Expression and characterization of human tissue inhibitor of metalloproteinases-1 in a baculovirus-insect cell system. Biochem Biophys Res Commun 203: 237-243, 1994.
17. DeClerck YA: Purification and characterization of a collagenase inhibitor produced by bovine vascular smooth muscle cells. Archives Biochem Biophys 265: 28-37, 1988.
18. DiPietro LA, Nebgen DR and Polverini PJ: Downregulation of endothelial cell thrombospondin 1 enhances in vitro angiogenesis. J Vasc Res 31: 178-185, 1994.
19. Gomez DE, Hartzler JL, Corbitt RH, Nason AM and Thorgeirsson UP: Immunomagnetic separation as a final purification step of liver endothelial cells. in vitro Cell Dev Biol 29A: 451-455, 1993.
20. Ballin M, Mackay AR, Hartzler JL, Nason A, Pelina MD and Thorgeirsson UP: Ras levels and metalloproteinase activity in normal versus neoplastic rat mammary tissues. Clin Exp Metastasis 9: 179-189, 1991.
21. Weidner N: Intratumoral microvessel density as a prognostic factor in cancer. Am J Pathol 147: 1-11, 1995.
22. Smith-McCune KK and Weidner N: Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res 54: 800-804, 1994.
23. Kandel J, Bossy-Wetzel E, Radvanyi F, Klagsbrun M, Folkman J and Hanahan D: Neovascularization is associated with a switch to the export of bFGF in multistep development of fibrosarcoma. Cell 66: 1095-1104, 1991.
24. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH and Folkman J: Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 70: 315-328, 1994.
25. Mignatti P, Tsuboi R, Robbins E and Rifkin DB: in vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J Cell Biol 105: 671-682, 1989.
26. Schnaper HW, Grant DS, Stetler-Stevenson WG, Fridman R, D'Orazi G, Murphy AN, Bird RE, Hoythya M, Fuerst TR, French DL, Quigley JP and Kleinman HK: Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J Cell Physiol 156: 235-246, 1993.
27. Takigawa M, Nishida Y, Suzuki F, Kishi J, Yamashita K and Hayakawa T: Induction of Angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2). Biochem Biophys Res Commun 171: 1264-1271, 1990.
28. Murphy AN, Unsworth EJ and Stetler-Stevenson WG: Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol 157: 351-358, 1993.
29. Fisher C, Gilbertson-Beadling S, Powers EA, Petzold G, Poorman R and Mitchell MA: Interstitial collagenase is required for angiogenesis in vitro. Dev Biol 162: 499-510, 1994.
30. Maragoudakis ME, Peristeris P, Missirlis E, Aletras A, Andriopoulou P and Haralabopoulos G: Inhibition of angiogenesis by anthracyclines and titanocene diehloride. Ann NY Acad Sci 752: 280-292, 1994.
31. Nagayama M, Sakamoto S and Sakamoto M: Mouse bone collagenase inhibitor: purification and partial characterization of the inhibitor from mouse calvaria cultures. Arch Biochem Biophys 228: 653-659, 1984.
32. Mercer E, Cawston TE, DeSilva M and Hazleman BL: Purification of a metalloproteinase inhibitor from human rheumatoid synovial fluid. Biochem J 231: 505-510, 1985.
33. Cawston TE, Noble DN, Murphy G, Smith AJ, Woodley C and Hazleman B: Rapid purification of tissue inhibitor of metalloproteinases from human plasma and identification as a t-serum protein. Biochem J 238: 677-682, 1986.
34. Schulke N and Schmid FX: Effect of glycosylation on the mechanism of renaturation of invertase from yeast. J Biol Chem 263: 8832-8837, 1988.
35. Jay JM and Stetler-Stevenson G: Gelatinase A activity directly modulates melanoma cell adhesion and spreading. EMBO J 14: 908-917, 1995.